Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer

MicroRNAs as Biomarkers in Colorectal Cancer

(2010) Kristina Schee et al.   AMERICAN JOURNAL OF PATHOLOGY

Diagnostic Value of the Hemopexin N-Glycan Profile in Hepatocellular Carcinoma Patients

(2010) E. N. Debruyne et al.   CLINICAL CHEMISTRY

Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer

(2010) Hitoshi Matsumoto et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Serum Markers of Hepatocellular Carcinoma

(2010) Giulia Malaguarnera et al.   DIGESTIVE DISEASES AND SCIENCES

Glycomic Analyses of Glycoproteins in Bile and Serum during Rat Hepatocarcinogenesis

(2010) Tsutomu Nakagawa et al.   JOURNAL OF PROTEOME RESEARCH

Novel Fucosylated Biomarkers for the Early Detection of Hepatocellular Carcinoma

(2009) M. Wang et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Deficiency of GMDS Leads to Escape from NK Cell-Mediated Tumor Surveillance Through Modulation of TRAIL Signaling

(2009) Kenta Moriwaki et al.   GASTROENTEROLOGY

N-glycosylation status of β-haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects

(2009) Seung-Yeol Park et al.   INTERNATIONAL JOURNAL OF CANCER

Identification of an inducible factor secreted by pancreatic cancer cell lines that stimulates the production of fucosylated haptoglobin in hepatoma cells

(2008) Megumi Narisada et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: A novel approach for the development of tumor markers

(2008) Miyako Nakano et al.   INTERNATIONAL JOURNAL OF CANCER